COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case-control study with SARS-CoV-2 genetic sequencing
<p><strong>INTRODUCTION:</strong> Inactivated, viral vector and mRNA vaccines have been used in the Nepali COVID-19 vaccination programme but there is little evidence on the effectiveness of these vaccines in this setting. The aim of this study is to describe COVID-19 vaccine effec...
Hoofdauteurs: | Bijukchhe, SM, O'Reilly, PJ, Theiss-Nyland, K, Gurung, M, Pokhrel, B, Kelly, S, Acharya, S, Maharjan, S, Shrestha, A, Pandey, B, Lama, M, Shrestha, I, Voysey, M, Eordogh, A, Shrestha, S, Feng, ES, Li, G, Shah, G, Pollard, AJ |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
BMJ Publishing Group
2023
|
Gelijkaardige items
Journal of The Nepal Medical Association- Editorial
door: S M Shrestha
Gepubliceerd in: (2003-01-01)
door: S M Shrestha
Gepubliceerd in: (2003-01-01)
Gelijkaardige items
-
COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case–control study with SARS-CoV-2 genetic sequencing
door: Andrew J Pollard, et al.
Gepubliceerd in: (2023-04-01) -
Childhood invasive bacterial disease in Kathmandu, Nepal (2005-2013)
door: Carter, MJ, et al.
Gepubliceerd in: (2021) -
Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study
door: Shrestha, S, et al.
Gepubliceerd in: (2022) -
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age
door: Bijukchhe, SM, et al.
Gepubliceerd in: (2024) -
Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) — a protocol for two parallel, open-label, randomised controlled trials
door: Kelly, S, et al.
Gepubliceerd in: (2023)